Other Species / Isoforms
  TANC2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S5-p
___MFRNsLKMLLtG
0 2
TANC2 (human) ___MFRNsLKMLLtG S5-p
TANC2 iso2 (human) ___MFRNSLKMLLTG S5
TANC2 (mouse) ___MFRNSLKMLLtG S5
TANC2 (rat) ___MFRNSLKMLLTG S5
T11-p
NsLKMLLtGGKSSRK
0 4
TANC2 (human) NsLKMLLtGGKSSRK T11-p
TANC2 iso2 (human) NSLKMLLTGGKSSRK T11
TANC2 (mouse) NSLKMLLtGGKsSRK T11-p
TANC2 (rat) NSLKMLLTGGKSSRK T11
S15
MLLtGGKSSRKNRSs
0 2
TANC2 (human) MLLtGGKSSRKNRSs S15
TANC2 iso2 (human) MLLTGGKSSRKNRSS S15
TANC2 (mouse) MLLtGGKsSRKNRSs S15-p
TANC2 (rat) MLLTGGKSSRKNRSS S15
S22-p
SSRKNRSsDGGSEEP
0 4
TANC2 (human) SSRKNRSsDGGSEEP S22-p
TANC2 iso2 (human) SSRKNRSSDGGSEEP S22
TANC2 (mouse) sSRKNRSsDGGSEEP S22-p
TANC2 (rat) SSRKNRSSDGGSEEP S22
S35-p
EPPDRRQsSVDSRQS
0 1
TANC2 (human) EPPDRRQsSVDSRQS S35-p
TANC2 iso2 (human) EPPDRRQSSVDSRQS S35
TANC2 (mouse) EPPDRRQSSVDSRQS S35
TANC2 (rat) EPPDRRQSSVDSRQS S35
S163-p
NATAKDCsYGAVTsP
0 1
TANC2 (human) NATAKDCsYGAVTsP S163-p
TANC2 iso2 (human) NATAKDCSYGAVTSP S163
TANC2 (mouse) NAAAKDCSYGAVTsP S163
TANC2 (rat) NATAKDCSYGAVTsP S163
S169-p
CsYGAVTsPtstLEs
Upstream
0 26
Treatment
  • Y27632
TANC2 (human) CsYGAVTsPtstLEs S169-p
TANC2 iso2 (human) CSYGAVTSPTSTLES S169
TANC2 (mouse) CSYGAVTsPtStLES S169-p
TANC2 (rat) CSYGAVTsPTSTLES S169-p
T171-p
YGAVTsPtstLEsRD
0 3
TANC2 (human) YGAVTsPtstLEsRD T171-p
TANC2 iso2 (human) YGAVTSPTSTLESRD T171
TANC2 (mouse) YGAVTsPtStLESRD T171-p
TANC2 (rat) YGAVTsPTSTLESRD T171
S172-p
GAVTsPtstLEsRDs
0 1
TANC2 (human) GAVTsPtstLEsRDs S172-p
TANC2 iso2 (human) GAVTSPTSTLESRDS S172
TANC2 (mouse) GAVTsPtStLESRDS S172
TANC2 (rat) GAVTsPTSTLESRDS S172
T173-p
AVTsPtstLEsRDsG
0 2
TANC2 (human) AVTsPtstLEsRDsG T173-p
TANC2 iso2 (human) AVTSPTSTLESRDSG T173
TANC2 (mouse) AVTsPtStLESRDSG T173-p
TANC2 (rat) AVTsPTSTLESRDSG T173
S176-p
sPtstLEsRDsGIIA
0 1
TANC2 (human) sPtstLEsRDsGIIA S176-p
TANC2 iso2 (human) SPTSTLESRDSGIIA S176
TANC2 (mouse) sPtStLESRDSGIIA S176
TANC2 (rat) sPTSTLESRDSGIIA S176
S179-p
stLEsRDsGIIATLT
0 1
TANC2 (human) stLEsRDsGIIATLT S179-p
TANC2 iso2 (human) STLESRDSGIIATLT S179
TANC2 (mouse) StLESRDSGIIATLT S179
TANC2 (rat) STLESRDSGIIATLT S179
K203-ub
KYAGESSkELGsGGN
0 1
TANC2 (human) KYAGESSkELGsGGN K203-ub
TANC2 iso2 (human) KYAGESSKELGSGGN K203
TANC2 (mouse) KYVGEGSKELGSGGN K203
TANC2 (rat) KYVGEAGKELGSGGN K203
S207-p
ESSkELGsGGNIkPW
0 2
TANC2 (human) ESSkELGsGGNIkPW S207-p
TANC2 iso2 (human) ESSKELGSGGNIKPW S207
TANC2 (mouse) EGSKELGSGGNLKPW S207
TANC2 (rat) EAGKELGSGGNLKPW S207
K212-ac
LGsGGNIkPWQsQkS
0 1
TANC2 (human) LGsGGNIkPWQsQkS K212-ac
TANC2 iso2 (human) LGSGGNIKPWQSQKS K212
TANC2 (mouse) LGSGGNLKPWQSQKS K212
TANC2 (rat) LGSGGNLKPWQSQKS K212
S216-p
GNIkPWQsQkSsMDS
0 1
TANC2 (human) GNIkPWQsQkSsMDS S216-p
TANC2 iso2 (human) GNIKPWQSQKSSMDS S216
TANC2 (mouse) GNLKPWQSQKSSMDS S216
TANC2 (rat) GNLKPWQSQKSSMDS S216
K218-ub
IkPWQsQkSsMDSCL
0 1
TANC2 (human) IkPWQsQkSsMDSCL K218-ub
TANC2 iso2 (human) IKPWQSQKSSMDSCL K218
TANC2 (mouse) LKPWQSQKSSMDSCL K218
TANC2 (rat) LKPWQSQKSSMDSCL K218
S220-p
PWQsQkSsMDSCLYR
0 1
TANC2 (human) PWQsQkSsMDSCLYR S220-p
TANC2 iso2 (human) PWQSQKSSMDSCLYR S220
TANC2 (mouse) PWQSQKSSMDSCLYR S220
TANC2 (rat) PWQSQKSSMDSCLYR S220
S235-p
VDENMTAstYsLNKI
0 1
TANC2 (human) VDENMTAstYsLNKI S235-p
TANC2 iso2 (human) VDENMTASTYSLNKI S235
TANC2 (mouse) VDENMAASTYsLNKI S235
TANC2 (rat) VDENMAASTYSLNKI S235
T236-p
DENMTAstYsLNKIP
0 1
TANC2 (human) DENMTAstYsLNKIP T236-p
TANC2 iso2 (human) DENMTASTYSLNKIP T236
TANC2 (mouse) DENMAASTYsLNKIP T236
TANC2 (rat) DENMAASTYSLNKIP T236
S238-p
NMTAstYsLNKIPER
0 5
TANC2 (human) NMTAstYsLNKIPER S238-p
TANC2 iso2 (human) NMTASTYSLNKIPER S238
TANC2 (mouse) NMAASTYsLNKIPER S238-p
TANC2 (rat) NMAASTYSLNKIPER S238
S252-p
RNLETVLsQsVQSIP
0 1
TANC2 (human) RNLETVLsQsVQSIP S252-p
TANC2 iso2 (human) RNLETVLSQSVQSIP S252
TANC2 (mouse) RNLETVLSQSVQSIP S252
TANC2 (rat) RNLETVLSQSVQSIP S252
S254-p
LETVLsQsVQSIPLY
0 1
TANC2 (human) LETVLsQsVQSIPLY S254-p
TANC2 iso2 (human) LETVLSQSVQSIPLY S254
TANC2 (mouse) LETVLSQSVQSIPLY S254
TANC2 (rat) LETVLSQSVQSIPLY S254
S268-p
YLMPRPNsVAATSSA
0 7
TANC2 (human) YLMPRPNsVAATSSA S268-p
TANC2 iso2 (human) YLMPRPNSVAATSSA S268
TANC2 (mouse) YLMPRPNSVAATSSA S268
TANC2 (rat) YLMPRPNSVAATSSA S268
S294-p
RHTPLRTsLRMPRQS
0 1
TANC2 (human) RHTPLRTsLRMPRQS S294-p
TANC2 iso2 (human) RHTPLRTSLRMPRQS S294
TANC2 (mouse) RHTPLRTSLRMPRQS S294
TANC2 (rat) RHTPLRTSLRMPRQS S294
S387-p
ISRLVALsCHGtRMR
0 1
TANC2 (human) ISRLVALsCHGtRMR S387-p
TANC2 iso2 (human) ISRLVALSCHGTRMR S387
TANC2 (mouse) ISRLVALSCHGTRMR S387
TANC2 (rat) ISRLVALSCHGTRMR S387
T391-p
VALsCHGtRMRQIAs
0 1
TANC2 (human) VALsCHGtRMRQIAs T391-p
TANC2 iso2 (human) VALSCHGTRMRQIAS T391
TANC2 (mouse) VALSCHGTRMRQIAS T391
TANC2 (rat) VALSCHGTRMRQIAS T391
S398-p
tRMRQIAsDsPHAsP
0 2
TANC2 (human) tRMRQIAsDsPHAsP S398-p
TANC2 iso2 (human) TRMRQIASDSPHASP S398
TANC2 (mouse) TRMRQIASDsPHAsP S398
TANC2 (rat) TRMRQIASDsPHAsP S398
S400-p
MRQIAsDsPHAsPKH
Upstream
0 28
Treatment
  • nocodazole
TANC2 (human) MRQIAsDsPHAsPKH S400-p
TANC2 iso2 (human) MRQIASDSPHASPKH S400
TANC2 (mouse) MRQIASDsPHAsPKH S400-p
TANC2 (rat) MRQIASDsPHAsPKH S400-p
S404-p
AsDsPHAsPKHVDAN
Upstream
0 27
Treatment
  • nocodazole
TANC2 (human) AsDsPHAsPKHVDAN S404-p
TANC2 iso2 (human) ASDSPHASPKHVDAN S404
TANC2 (mouse) ASDsPHAsPKHVDAN S404-p
TANC2 (rat) ASDsPHAsPKHVDAN S404-p
T417-p
ANRELPLtQPPsAHs
0 1
TANC2 (human) ANRELPLtQPPsAHs T417-p
TANC2 iso2 (human) ANRELPLTQPPSAHS T417
TANC2 (mouse) ANRELPLTQAPSAHS T417
TANC2 (rat) ANRELPLTQAPSAHS T417
S421-p
LPLtQPPsAHsSITs
0 2
TANC2 (human) LPLtQPPsAHsSITs S421-p
TANC2 iso2 (human) LPLTQPPSAHSSITS S421
TANC2 (mouse) LPLTQAPSAHSsITS S421
TANC2 (rat) LPLTQAPSAHSSIAS S421
S424-p
tQPPsAHsSITsGsC
0 1
TANC2 (human) tQPPsAHsSITsGsC S424-p
TANC2 iso2 (human) TQPPSAHSSITSGSC S424
TANC2 (mouse) TQAPSAHSsITSGsC S424
TANC2 (rat) TQAPSAHSSIASGSC S424
S425
QPPsAHsSITsGsCP
0 1
TANC2 (human) QPPsAHsSITsGsCP S425
TANC2 iso2 (human) QPPSAHSSITSGSCP S425
TANC2 (mouse) QAPSAHSsITSGsCP S425-p
TANC2 (rat) QAPSAHSSIASGSCP S425
S428-p
sAHsSITsGsCPGtP
Upstream
0 3
Treatment
  • Y27632
TANC2 (human) sAHsSITsGsCPGtP S428-p
TANC2 iso2 (human) SAHSSITSGSCPGTP S428
TANC2 (mouse) SAHSsITSGsCPGtP S428
TANC2 (rat) SAHSSIASGSCPGTP S428
S430-p
HsSITsGsCPGtPEM
0 12
TANC2 (human) HsSITsGsCPGtPEM S430-p
TANC2 iso2 (human) HSSITSGSCPGTPEM S430
TANC2 (mouse) HSsITSGsCPGtPEM S430-p
TANC2 (rat) HSSIASGSCPGTPEM S430
T434-p
TsGsCPGtPEMRRRQ
Upstream
0 38
Treatment
  • Y27632
TANC2 (human) TsGsCPGtPEMRRRQ T434-p
TANC2 iso2 (human) TSGSCPGTPEMRRRQ T434
TANC2 (mouse) TSGsCPGtPEMRRRQ T434-p
TANC2 (rat) ASGSCPGTPEMRRRQ T434
T637-p
LNGKMDNtTFGkLSS
0 1
TANC2 (human) LNGKMDNtTFGkLSS T637-p
TANC2 iso2 (human) LNGKMDNTTFGKLSS T637
TANC2 (mouse) LNGKMDNTTFGKLSS T637
TANC2 (rat) LNGKMDNTTFGkLSS T637
K641
MDNtTFGKLSSHLKT
0 1
TANC2 (human) MDNtTFGKLSSHLKT K641
TANC2 iso2 (human) MDNTTFGKLSSHLKT K641
TANC2 (mouse) MDNTTFGKLSSHLKT K641
TANC2 (rat) MDNTTFGkLSSHLKT K641-ac
K641-ub
MDNtTFGkLSSHLKT
0 1
TANC2 (human) MDNtTFGkLSSHLKT K641-ub
TANC2 iso2 (human) MDNTTFGKLSSHLKT K641
TANC2 (mouse) MDNTTFGKLSSHLKT K641
TANC2 (rat) MDNTTFGKLSSHLKT K641
S749-p
QQRMENLsMFLIKRR
Upstream
0 4
Treatment
  • dasatinib
TANC2 (human) QQRMENLsMFLIKRR S749-p
TANC2 iso2 (human) QQRMENLSMFLIKRR S749
TANC2 (mouse) QQRMENLSMFLIKRR S749
TANC2 (rat) QQRMENLSMFLIKRR S749
K818
ELGHHILKAHIFKGL
0 1
TANC2 (human) ELGHHILKAHIFKGL K818
TANC2 iso2 (human) ELGHHILKAHIFKGL K818
TANC2 (mouse) ELGHHILKAHIFKGL K818
TANC2 (rat) ELGHHILkAHIFKGL K818-ac
Y859-p
LASLRNLyTPNIKVS
0 1
TANC2 (human) LASLRNLyTPNIKVS Y859-p
TANC2 iso2 (human) LASLRNLYTPNIKVS Y859
TANC2 (mouse) LASLRNLYTPNIKVS Y859
TANC2 (rat) LASLRNLYTPNIKVS Y859
T1159-p
LVDNGAAtDHADKNG
Upstream
0 1
Treatment
  • nocodazole
TANC2 (human) LVDNGAAtDHADKNG T1159-p
TANC2 iso2 (human) LVDNGAATDHADKNG T1159
TANC2 (mouse) LVDNGAATDHADKNG T1159
TANC2 (rat) LVDNGAATDHADKNG T1159
K1284-ub
EGFGEDLkTFRELKV
0 1
TANC2 (human) EGFGEDLkTFRELKV K1284-ub
TANC2 iso2 (human) EGFGEDLKTFRELKV K1294
TANC2 (mouse) EGFGEDLKTFRELKV K1284
TANC2 (rat) EGFGEDLKTFRELKV K1284
K1303
NLSRCRRKMNDFGMA
0 1
TANC2 (human) NLSRCRRKMNDFGMA K1303
TANC2 iso2 (human) NLSRCRRKMNDFGMA K1313
TANC2 (mouse) NLSRCRRkMNDFGMA K1303-ac
TANC2 (rat) NLSRCRRKMNDFGMA K1303
K1316-ac
MAEEFATkALELKPK
0 1
TANC2 (human) MAEEFATkALELKPK K1316-ac
TANC2 iso2 (human) MAEEFATKALELKPK K1326
TANC2 (mouse) MAEEFATKALELKPK K1316
TANC2 (rat) MAEEFATKALELKPK K1316
S1442-p
QGLPVIQsPPssPPH
Upstream
0 18
Treatment
  • LRRK2-IN-1
  • selumetinib
  • vemurafenib
TANC2 (human) QGLPVIQsPPssPPH S1442-p
TANC2 iso2 (human) QGLPVIQSPPSSPPH S1452
TANC2 (mouse) QGLPVIQsPPSSPAH S1446-p
TANC2 (rat) QGLPVIQsPPSSPAH S1444-p
S1445-p
PVIQsPPssPPHRDS
0 2
TANC2 (human) PVIQsPPssPPHRDS S1445-p
TANC2 iso2 (human) PVIQSPPSSPPHRDS S1455
TANC2 (mouse) PVIQsPPSSPAHRDS S1449
TANC2 (rat) PVIQsPPSSPAHRDS S1447
S1446-p
VIQsPPssPPHRDSA
0 7
TANC2 (human) VIQsPPssPPHRDSA S1446-p
TANC2 iso2 (human) VIQSPPSSPPHRDSA S1456
TANC2 (mouse) VIQsPPSSPAHRDSA S1450
TANC2 (rat) VIQsPPSSPAHRDSA S1448
S1456-p
HRDSAYIsssPLGsH
0 1
TANC2 (human) HRDSAYIsssPLGsH S1456-p
TANC2 iso2 (human) HRDSAYISSSPLGSH S1466
TANC2 (mouse) HRDSAYISssPLGsH S1460
TANC2 (rat) HRDSAYISSSPLGSH S1458
S1457-p
RDSAYIsssPLGsHQ
0 5
TANC2 (human) RDSAYIsssPLGsHQ S1457-p
TANC2 iso2 (human) RDSAYISSSPLGSHQ S1467
TANC2 (mouse) RDSAYISssPLGsHQ S1461-p
TANC2 (rat) RDSAYISSSPLGSHQ S1459
S1458-p
DSAYIsssPLGsHQV
Upstream
0 11
Treatment
  • metastatic potential
  • Y27632
TANC2 (human) DSAYIsssPLGsHQV S1458-p
TANC2 iso2 (human) DSAYISSSPLGSHQV S1468
TANC2 (mouse) DSAYISssPLGsHQV S1462-p
TANC2 (rat) DSAYISSSPLGSHQV S1460
S1462-p
IsssPLGsHQVFDFR
0 6
TANC2 (human) IsssPLGsHQVFDFR S1462-p
TANC2 iso2 (human) ISSSPLGSHQVFDFR S1472
TANC2 (mouse) ISssPLGsHQVFDFR S1466-p
TANC2 (rat) ISSSPLGSHQVFDFR S1464
S1476-p
RSSSSVGsPTRQTYQ
0 4
TANC2 (human) RSSSSVGsPTRQTYQ S1476-p
TANC2 iso2 (human) RSSSSVGSPTRQTYQ S1486
TANC2 (mouse) RSNSSVGsPtRQGYQ S1480-p
TANC2 (rat) RSNSSVGSPTRQGYQ S1478
T1478
SSSVGsPTRQTYQST
0 1
TANC2 (human) SSSVGsPTRQTYQST T1478
TANC2 iso2 (human) SSSVGSPTRQTYQST T1488
TANC2 (mouse) NSSVGsPtRQGYQST T1482-p
TANC2 (rat) NSSVGSPTRQGYQST T1480
S1517-p
QGGSYRFsPPPVGGQ
0 6
TANC2 (human) QGGSYRFsPPPVGGQ S1517-p
TANC2 iso2 (human) QGGSYRFSPPPVGGQ S1527
TANC2 (mouse) QGASYRFsPPPVGGQ S1521-p
TANC2 (rat) QGASYRFSPPPVGGQ S1519
S1530-p
GQGKEYPsPPPsPLR
Upstream
0 30
Treatment
  • selumetinib
  • vemurafenib
TANC2 (human) GQGKEYPsPPPsPLR S1530-p
TANC2 iso2 (human) GQGKEYPSPPPSPLR S1540
TANC2 (mouse) GQSKEYPsPPPsPLR S1534-p
TANC2 (rat) GQGKEYPsPPPSPLR S1532-p
S1534-p
EYPsPPPsPLRRGPQ
Upstream
0 26
Treatment
  • selumetinib
  • vemurafenib
TANC2 (human) EYPsPPPsPLRRGPQ S1534-p
TANC2 iso2 (human) EYPSPPPSPLRRGPQ S1544
TANC2 (mouse) EYPsPPPsPLRRGPQ S1538-p
TANC2 (rat) EYPsPPPSPLRRGPQ S1536
R1543-m1
LRRGPQYrAsPPAES
0 1
TANC2 (human) LRRGPQYrAsPPAES R1543-m1
TANC2 iso2 (human) LRRGPQYRASPPAES R1553
TANC2 (mouse) LRRGPQYRAsPPAES R1547
TANC2 (rat) LRRGPQYRAsPPAES R1545
S1545-p
RGPQYrAsPPAESMS
Upstream
0 19
Treatment
  • ischemia
TANC2 (human) RGPQYrAsPPAESMS S1545-p
TANC2 iso2 (human) RGPQYRASPPAESMS S1555
TANC2 (mouse) RGPQYRAsPPAESMs S1549-p
TANC2 (rat) RGPQYRAsPPAESMS S1547-p
S1552
sPPAESMSVYRsQsG
0 1
TANC2 (human) sPPAESMSVYRsQsG S1552
TANC2 iso2 (human) SPPAESMSVYRSQSG S1562
TANC2 (mouse) sPPAESMsVYRSQSG S1556-p
TANC2 (rat) sPPAESMSIYRSQSG S1554
S1556-p
ESMSVYRsQsGsPVR
0 2
TANC2 (human) ESMSVYRsQsGsPVR S1556-p
TANC2 iso2 (human) ESMSVYRSQSGSPVR S1566
TANC2 (mouse) ESMsVYRSQSGsPVr S1560
TANC2 (rat) ESMSIYRSQSGSPVR S1558
S1558-p
MSVYRsQsGsPVRYQ
0 2
TANC2 (human) MSVYRsQsGsPVRYQ S1558-p
TANC2 iso2 (human) MSVYRSQSGSPVRYQ S1568
TANC2 (mouse) MsVYRSQSGsPVrYQ S1562
TANC2 (rat) MSIYRSQSGSPVRYQ S1560
S1560-p
VYRsQsGsPVRYQQE
0 9
TANC2 (human) VYRsQsGsPVRYQQE S1560-p
TANC2 iso2 (human) VYRSQSGSPVRYQQE S1570
TANC2 (mouse) VYRSQSGsPVrYQQE S1564-p
TANC2 (rat) IYRSQSGSPVRYQQE S1562
R1563
sQsGsPVRYQQETSV
0 3
TANC2 (human) sQsGsPVRYQQETSV R1563
TANC2 iso2 (human) SQSGSPVRYQQETSV R1573
TANC2 (mouse) SQSGsPVrYQQETNV R1567-m2
TANC2 (rat) SQSGSPVRYQQEANV R1565
R1576
SVSQLPGRPKsPLsk
0 3
TANC2 (human) SVSQLPGRPKsPLsk R1576
TANC2 iso2 (human) SVSQLPGRPKSPLSK R1586
TANC2 (mouse) NVSQLPGrPKsPLsK R1580-m2
TANC2 (rat) NVSQLPGRPKsPLSK R1578
S1579-p
QLPGRPKsPLskMAQ
0 65
TANC2 (human) QLPGRPKsPLskMAQ S1579-p
TANC2 iso2 (human) QLPGRPKSPLSKMAQ S1589
TANC2 (mouse) QLPGrPKsPLsKMAQ S1583-p
TANC2 (rat) QLPGRPKsPLSKMAQ S1581-p
S1582-p
GRPKsPLskMAQRPY
0 9
TANC2 (human) GRPKsPLskMAQRPY S1582-p
TANC2 iso2 (human) GRPKSPLSKMAQRPY S1592
TANC2 (mouse) GrPKsPLsKMAQRPY S1586-p
TANC2 (rat) GRPKsPLSKMAQRPY S1584
K1583-ac
RPKsPLskMAQRPYQ
0 1
TANC2 (human) RPKsPLskMAQRPYQ K1583-ac
TANC2 iso2 (human) RPKSPLSKMAQRPYQ K1593
TANC2 (mouse) rPKsPLsKMAQRPYQ K1587
TANC2 (rat) RPKsPLSKMAQRPYQ K1585
R1604
AVPQQGLRLQPAkAQ
0 3
TANC2 (human) AVPQQGLRLQPAkAQ R1604
TANC2 iso2 (human) AVPQQGLRLQPAKAQ R1614
TANC2 (mouse) AVPQQGLrLQPAKAQ R1608-m1
TANC2 (rat) AVPQQGLRLQPAKAQ R1606
K1609-ub
GLRLQPAkAQIVRSN
0 1
TANC2 (human) GLRLQPAkAQIVRSN K1609-ub
TANC2 iso2 (human) GLRLQPAKAQIVRSN K1619
TANC2 (mouse) GLrLQPAKAQIVRSN K1613
TANC2 (rat) GLRLQPAKAQIVRSN K1611
S1619-p
IVRSNQPsPAVHSST
0 2
TANC2 (human) IVRSNQPsPAVHSST S1619-p
TANC2 iso2 (human) IVRSNQPSPAVHSST S1629
TANC2 (mouse) IVRSNQPSSAVHSST S1623
TANC2 (rat) IVRSNQPSSAVHSST S1621
Y1633
TVIPTGAYGQVAHSM
0 5
TANC2 (human) TVIPTGAYGQVAHSM Y1633
TANC2 iso2 (human) TVIPTGAYGQVAHSM Y1643
TANC2 (mouse) TVIPTGAyGQVAHsM Y1637-p
TANC2 (rat) TVIPTGAyGQVAHPM Y1635-p
S1639
AYGQVAHSMASKYQS
0 1
TANC2 (human) AYGQVAHSMASKYQS S1639
TANC2 iso2 (human) AYGQVAHSMASKYQS S1649
TANC2 (mouse) AyGQVAHsMASKYQS S1643-gl
TANC2 (rat) AyGQVAHPMASKYQS P1641
S1647-p
MASKYQSsQGDIGVS
0 5
TANC2 (human) MASKYQSsQGDIGVS S1647-p
TANC2 iso2 (human) MASKYQSSQGDIGVS S1657
TANC2 (mouse) MASKYQSSQGDMGVs S1651
TANC2 (rat) MASKYQSSQGDMGVS S1649
S1654
sQGDIGVSQSRLVYQ
0 2
TANC2 (human) sQGDIGVSQSRLVYQ S1654
TANC2 iso2 (human) SQGDIGVSQSRLVYQ S1664
TANC2 (mouse) SQGDMGVsQsRLVYQ S1658-p
TANC2 (rat) SQGDMGVSQSRLVYQ S1656
S1656
GDIGVSQSRLVYQGs
0 1
TANC2 (human) GDIGVSQSRLVYQGs S1656
TANC2 iso2 (human) GDIGVSQSRLVYQGS S1666
TANC2 (mouse) GDMGVsQsRLVYQGS S1660-p
TANC2 (rat) GDMGVSQSRLVYQGS S1658
S1663-p
SRLVYQGsIGGIVGD
0 1
TANC2 (human) SRLVYQGsIGGIVGD S1663-p
TANC2 iso2 (human) SRLVYQGSIGGIVGD S1673
TANC2 (mouse) sRLVYQGSIGGIVGD S1667
TANC2 (rat) SRLVYQGSIGGIVGD S1665
R1700-m1
TKEDLPQrPSSAyrG
0 1
TANC2 (human) TKEDLPQrPSSAyrG R1700-m1
TANC2 iso2 (human) TKEDLPQRPSSAYRG R1710
TANC2 (mouse) TKEDLPQRPSSAYRG R1704
TANC2 (rat) TKEDLPQRPSSAYRG R1702
Y1705-p
PQrPSSAyrGGVrYS
0 1
TANC2 (human) PQrPSSAyrGGVrYS Y1705-p
TANC2 iso2 (human) PQRPSSAYRGGVRYS Y1715
TANC2 (mouse) PQRPSSAYRGGMRYS Y1709
TANC2 (rat) PQRPSSAYRGGMRYS Y1707
R1706-m1
QrPSSAyrGGVrYSQ
0 5
TANC2 (human) QrPSSAyrGGVrYSQ R1706-m1
TANC2 iso2 (human) QRPSSAYRGGVRYSQ R1716
TANC2 (mouse) QRPSSAYRGGMRYSQ R1710
TANC2 (rat) QRPSSAYRGGMRYSQ R1708
R1710-m1
SAyrGGVrYSQtPQI
0 1
TANC2 (human) SAyrGGVrYSQtPQI R1710-m1
TANC2 iso2 (human) SAYRGGVRYSQTPQI R1720
TANC2 (mouse) SAYRGGMRYSQTPQI R1714
TANC2 (rat) SAYRGGMRYSQTPQI R1712
T1714-p
GGVrYSQtPQIGRsQ
0 1
TANC2 (human) GGVrYSQtPQIGRsQ T1714-p
TANC2 iso2 (human) GGVRYSQTPQIGRSQ T1724
TANC2 (mouse) GGMRYSQTPQIGRsQ T1718
TANC2 (rat) GGMRYSQTPQIGRSQ T1716
S1720-p
QtPQIGRsQsASyyP
0 1
TANC2 (human) QtPQIGRsQsASyyP S1720-p
TANC2 iso2 (human) QTPQIGRSQSASYYP S1730
TANC2 (mouse) QTPQIGRSQsASYYP S1724
TANC2 (rat) QTPQIGRSQSASyYP S1722
S1720
QtPQIGRSQsASyyP
0 1
TANC2 (human) QtPQIGRSQsASyyP S1720
TANC2 iso2 (human) QTPQIGRSQSASYYP S1730
TANC2 (mouse) QTPQIGRsQsASYYP S1724-gl
TANC2 (rat) QTPQIGRSQSASyYP S1722
S1722-p
PQIGRsQsASyyPVC
0 12
TANC2 (human) PQIGRsQsASyyPVC S1722-p
TANC2 iso2 (human) PQIGRSQSASYYPVC S1732
TANC2 (mouse) PQIGRsQsASYYPVC S1726-p
TANC2 (rat) PQIGRSQSASyYPVC S1724
Y1725-p
GRsQsASyyPVCHSK
Upstream
0 34
Treatment
  • ephrin_B1
TANC2 (human) GRsQsASyyPVCHSK Y1725-p
TANC2 iso2 (human) GRSQSASYYPVCHSK Y1735
TANC2 (mouse) GRsQsASYYPVCHSK Y1729
TANC2 (rat) GRSQSASyYPVCHSK Y1727-p
Y1726-p
RsQsASyyPVCHSKL
0 6
TANC2 (human) RsQsASyyPVCHSKL Y1726-p
TANC2 iso2 (human) RSQSASYYPVCHSKL Y1736
TANC2 (mouse) RsQsASYYPVCHSKL Y1730
TANC2 (rat) RSQSASyYPVCHSKL Y1728
S1738-p
SKLDLERsssQLGsP
0 4
TANC2 (human) SKLDLERsssQLGsP S1738-p
TANC2 iso2 (human) SKLDLERSSSQLGSP S1748
TANC2 (mouse) SKLDLERSSsQLGsP S1742
TANC2 (rat) SKLDLERSSSQLGSP S1740
S1739-p
KLDLERsssQLGsPD
0 11
TANC2 (human) KLDLERsssQLGsPD S1739-p
TANC2 iso2 (human) KLDLERSSSQLGSPD S1749
TANC2 (mouse) KLDLERSSsQLGsPD S1743
TANC2 (rat) KLDLERSSSQLGSPD S1741
S1740-p
LDLERsssQLGsPDV
0 45
TANC2 (human) LDLERsssQLGsPDV S1740-p
TANC2 iso2 (human) LDLERSSSQLGSPDV S1750
TANC2 (mouse) LDLERSSsQLGsPDV S1744-p
TANC2 (rat) LDLERSSSQLGSPDV S1742
S1744-p
RsssQLGsPDVsHLI
0 7
TANC2 (human) RsssQLGsPDVsHLI S1744-p
TANC2 iso2 (human) RSSSQLGSPDVSHLI S1754
TANC2 (mouse) RSSsQLGsPDVSHLI S1748-p
TANC2 (rat) RSSSQLGSPDVSHLI S1746
S1748-p
QLGsPDVsHLIRRPI
0 3
TANC2 (human) QLGsPDVsHLIRRPI S1748-p
TANC2 iso2 (human) QLGSPDVSHLIRRPI S1758
TANC2 (mouse) QLGsPDVSHLIRRPI S1752
TANC2 (rat) QLGSPDVSHLIRRPI S1750
R1770-m1
KPHPPTPrPLLHsQS
0 1
TANC2 (human) KPHPPTPrPLLHsQS R1770-m1
TANC2 iso2 (human) KPHPPTPRPLLHSQS R1780
TANC2 (mouse) KPHPPTPRPLLHSQs R1774
TANC2 (rat) KPHPPTPRPLLHSQS R1772
S1775-p
TPrPLLHsQSVGLrF
0 1
TANC2 (human) TPrPLLHsQSVGLrF S1775-p
TANC2 iso2 (human) TPRPLLHSQSVGLRF S1785
TANC2 (mouse) TPRPLLHSQsVGLRF S1779
TANC2 (rat) TPRPLLHSQSVGLRF S1777
S1777
rPLLHsQSVGLrFSP
0 1
TANC2 (human) rPLLHsQSVGLrFSP S1777
TANC2 iso2 (human) RPLLHSQSVGLRFSP S1787
TANC2 (mouse) RPLLHSQsVGLRFSP S1781-p
TANC2 (rat) RPLLHSQSVGLRFSP S1779
R1781-m1
HsQSVGLrFSPSSNS
0 1
TANC2 (human) HsQSVGLrFSPSSNS R1781-m1
TANC2 iso2 (human) HSQSVGLRFSPSSNS R1791
TANC2 (mouse) HSQsVGLRFSPSSNS R1785
TANC2 (rat) HSQSVGLRFSPSSNS R1783
S1819-p
LKPAYERsCDELsPV
0 2
TANC2 (human) LKPAYERsCDELsPV S1819-p
TANC2 iso2 (human) LKPAYERSCDELSPV S1829
TANC2 (mouse) LKPAYDRSCDELsPV S1823
TANC2 (rat) LKPAYDRSCDELSPV S1821
S1824-p
ERsCDELsPVsPtQG
Upstream
0 12
Treatment
  • CXCL12
  • ischemia
TANC2 (human) ERsCDELsPVsPtQG S1824-p
TANC2 iso2 (human) ERSCDELSPVSPTQG S1834
TANC2 (mouse) DRSCDELsPVsPTQG S1828-p
TANC2 (rat) DRSCDELSPVSPTQG S1826
S1827-p
CDELsPVsPtQGGYP
Upstream
0 19
Treatment
  • EGF
  • ischemia